{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T09:04:20Z","timestamp":1786611860036,"version":"build-2736575974"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2010,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>A 27-year-old woman without known risk factors contracted HIV and was given highly active antiretroviral therapy in 2006. She subsequently developed myasthenia gravis (MG) that responded to treatment with pyridostigmine bromide and azathioprine. The medical literature, consisting primarily of case reports, indicates that MG occurs in relatively immunocompetent HIV-infected persons who generally present with mild MG symptoms. As such, we recommend a high index of suspicion for MG in HIV-infected patients presenting with fatigue and weakness, especially those receiving highly active antiretroviral therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/cnd.0b013e3181fb1be7","type":"journal-article","created":{"date-parts":[[2010,11,15]],"date-time":"2010-11-15T23:49:42Z","timestamp":1289864982000},"page":"80-84","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":16,"title":["Comorbid HIV and Myasthenia Gravis: Case Report and Review of the Literature"],"prefix":"10.1097","volume":"12","author":[{"given":"Lisa","family":"Knopf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel L","family":"Menkes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20240808","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/mus.20338","article-title":"Skeletal muscle involvement in HIV-infected patients in the era of highly active antiretroviral (HAART) therapy.","volume":"32","author":"Authier","year":"2005","journal-title":"Muscle Nerve"},{"key":"R2-5-20240808","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1212\/WNL.40.4.581","article-title":"Immune studies in human immunodeficiency virus infection with myasthenia gravis: a case report.","volume":"40","author":"Nath","year":"1990","journal-title":"Neurology"},{"key":"R3-5-20240808","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0002-9343(94)90024-8","article-title":"Effect of corticosteroid therapy on human immunodeficiency virus-associated nephropathy.","volume":"97","author":"Smith","year":"1994","journal-title":"Am J Med"},{"key":"R4-5-20240808","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/(SICI)1097-4598(199805)21:5<680::AID-MUS26>3.0.CO;2-Y","article-title":"Ritonavir-associated myasthenia gravis.","volume":"21","author":"Saadat","year":"1998","journal-title":"Muscle Nerve"},{"key":"R5-5-20240808","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1093\/clinids\/15.2.379","article-title":"Recovery from myasthenia gravis of a patient infected with human immunodeficiency virus.","volume":"15","author":"Vittecoq","year":"1992","journal-title":"Clin Infect Dis"},{"key":"R6-5-20240808","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1097\/00002030-200311210-00022","article-title":"Efavirenz-containing highly active antiretroviral therapy in an HIV-infected patient with myasthenia gravis.","volume":"17","author":"Chiesa","year":"2003","journal-title":"AIDS"},{"key":"R7-5-20240808","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1017\/S0317167100034119","article-title":"Seronegative myasthenia gravis and human immunodeficiency virus infection: response to intravenous gamma globulin and prednisone.","volume":"25","author":"Strong","year":"1998","journal-title":"Can J Neurol Sci"},{"key":"R8-5-20240808","first-page":"995","article-title":"HIV infection with myasthenia gravis.","volume":"53","author":"Gorthi","year":"2005","journal-title":"J Assoc Physicians India"},{"key":"R9-5-20240808","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1002\/mus.880180819","article-title":"Transient myasthenia gravis during HIV infection.","volume":"18","author":"Authier","year":"1995","journal-title":"Muscle Nerve"},{"key":"R10-5-20240808","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S1568-9972(02)00086-1","article-title":"HIV and autoimmunity.","volume":"1","author":"Zandman-Goddard","year":"2002","journal-title":"Autoimmunity Reviews"},{"key":"R11-5-20240808","first-page":"1329","article-title":"The thymus in acquired immune deficiency syndrome: comparison with other types of immunodeficiency diseases, and presence of components of human immunodeficiency virus type 1.","volume":"134","author":"Schuurman","year":"1989","journal-title":"Am J Pathol"},{"key":"R12-5-20240808","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1212\/WNL.55.1.16","article-title":"Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America.","volume":"55","author":"Jaretzki","year":"2000","journal-title":"Neurology"},{"key":"R13-5-20240808","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1002\/(SICI)1097-4598(199609)19:9<1186::AID-MUS19>3.0.CO;2-T","article-title":"Acetylcholine receptor antibodies as a marker of treatable fatigue in HIV-1 infected individuals.","volume":"19","author":"Cupler","year":"1996","journal-title":"Muscle Nerve"},{"key":"R14-5-20240808","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/08916930903518107","article-title":"Immunosuppressive therapies in myasthenia gravis.","volume":"43","author":"Sanders","year":"2010","journal-title":"Autoimmunity"}],"container-title":["Journal of Clinical Neuromuscular Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00131402-201012000-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:45:14Z","timestamp":1786041914000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00131402-201012000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/cnd.0b013e3181fb1be7","relation":{},"ISSN":["1522-0443"],"issn-type":[{"value":"1522-0443","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}